------ =_NextPart_000_01BCD54C.76AAFF40
Content-Type: text/plain;
charset="iso-8859-1"
We have found the viability of "large cell lymphoma-cells" to be a
really low percentage. When the pathologist suspects "large cell",
our paneling procedure immediately becomes Stat! Unfortunately, no
matter how fast we respond, the viability is usually less than 40%
in
our disaggregated mix of cells -- and often less then 20%. We feel
it
is the large cells which are "going away". We try to gate around
the
area in which the large cells would be, and on occaision we are
able
to find a monoclonal population.
Kathy Altig
Providence Med Ctr.
Portland, OR
______________________________ Reply Separator
_________________________________
Subject: Re[2]: large cell lymphoma
Author: ,mann0002@mc.duke.edu [SMTP:mann0002@mc.duke.edu] at PHSOR
Date: 10/9/97 3:30 PM
We have had the identical experience and likewise have not seen evidence
of a
large cell population by light scatter characteristics.
Karen
Karen Mann, MD PhD
Duke University Medical Center
Durham, NC
________________________________________________________________________
_______
Subject: Re: large cell lymphoma
From: mkornste@hsc.vcu.edu at internet
Date: 10/09/97 6:50 AM
I have also been surprised by unremarkable flow data
from an FNA of an obvious large cell lymphoma (phenotyped as B cell by
immunocytochemistry). I like the idea that the cells were
fragile. No population of large cells by forward scatter were apparent.
/Michael Kornstein, MD, Medical College of Virginia, Richmond
On Wed, 8 Oct 1997, Brent Dorsett wrote:
>
>
> >Viki Mosiman
> >Robert H Lurie Cancer Center
> >Flow Cytometry Core Facility
> >Northwestern University Medical School
> >Chicago, IL
> >vlm646@nwu.edu
> >
> >I am interested in an opinion on the best way to detect Large-cell
> >lymphoma(B Cell type) in lymph nodes.
> >
> >We currently disaggregate nodes then surface stain using
> >45/19/kappa/lambda. Although
> >we often have success ,there are cases where clearly the node is a
> >malignant B-cell lymphoma by morphology in Surgical Pathology but we
see
> >no evidence in Flow. We have tried blocking with fetal calf and
mouse
> >serum. We have tried different gating strategies such as 45ss
combined
> >with 19ss gating or combined with fs. We have tried different
staining
> >combinations -19/5/kappa/lambda-45/19/10/kappa&45/19/10/lambda. We
have
> >tried live dead assays(7AAD) combined with surface staining in case a
node
> >was necrotic. Someone even suggested injecting nodes with PBS to
express
> >cells instead of mincing and grinding lymph nodes(they thought this
might
> >be a more gentle process).
> >
> >We don't seem to have the same problem with other malignant lymphomas
in
> >lymph nodes,just with the diagnosis of Large-cell lymphoma ( B-Cell
type).
> >Any suggestions would be greatly appreciated. Thanks for your help!
> >
> >Clinical Flow Lab
> >Northwestern Memorial Hospital
> >
> >
> Viki,
>
> Recently we have seen several cases where the malignant population in
large
> cell lymphomas was extremely difficult to demonstrate in flow. One, a
lymph
> node, was easily demonstrated by immunohistology to consist of large
numbers
> of B cells infiltrated with reactive T cells. In flow cytometry after
the
> usual mechanical disaggregation, suspesion in RPMI 1640 + 5% FCS,
filtering
> through 100 micro nylon mesh and washing almost no malignant B cells
could
> be detected. The second was a FNA of a mass in the liver collected
into RPMI
> 1640. This too immunostained positively as large B-cells, but in flow
was
> composed of 99% small to medium T-cells. Cell viability was good in
both
> preparations but there appeared to be substantil very small debris.
I'm
> guessing that these large cells were particularly fragile -- although
the
> appearance of the FNA cells in histology seemed normal. I would be
> interested in the experience of other with large cell lymphomas.
>
> Brent Dorsett
> Special Pathology Laboratory
> Lenox Hill Hospital
> NYC
>
>
RFC-822-headers:
Received: from nexus.mc.duke.edu by mc.duke.edu (PMDF V5.1-10 #23776)
with ESMTP id <0EHS00M1HXG1DD@mc.duke.edu>; Thu,
9 Oct 1997 16:57:07 -0400 (EDT)
Received: from flowcyt.cyto.purdue.edu
(flowcyt.cyto.purdue.edu [128.210.60.31]) by nexus.mc.duke.edu
(8.7.5/8.7.3)
with SMTP id NAA01099; Thu, 09 Oct 1997 13:57:36 -0400 (EDT)
Received: by flowcyt.cyto.purdue.edu (940816.SGI.8.6.9/930416.SGI.AUTO)
for cyto-sendout id KAA13098; Thu, 09 Oct 1997 10:30:01 -0500
Received: from dragon.vcu.edu by flowcyt.cyto.purdue.edu via ESMTP
(940816.SGI.8.6.9/930416.SGI.AUTO) for
<cytometry@flowcyt.cyto.purdue.edu> id
HAA12802; Thu, 09 Oct 1997 07:12:22 -0500
Received: from comet.vcu.edu ([128.172.2.33])
by dragon.vcu.edu (Netscape Mail Server v2.02) with SMTP id AAA10035;
Thu,
09 Oct 1997 07:47:44 -0400
Date: Thu, 09 Oct 1997 07:50:09 -0400 (EDT)
From: mkornste@hsc.vcu.edu (mkornste)
Subject: Re: large cell lymphoma
In-reply-to: <1.5.4.16.19971008173330.315fd1de@nyct.net>
X-Sender: mkornste@comet.vcu.edu
To: cyto-inbox
Cc: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu>
Message-id: <Pine.A41.3.96.971009074501.12590A-100000@comet.vcu.edu>
MIME-version: 1.0
Content-type: TEXT/PLAIN; charset=US-ASCII
------ =_NextPart_000_01BCD54C.76AAFF40
Content-Type: application/ms-tnef
Content-Transfer-Encoding: base64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------ =_NextPart_000_01BCD54C.76AAFF40--